Clinical Trials Sponsored by Nermina Rizvanović

Total 61 results

Nermina Rizvanović

Completed

Preoperative Administration of Oral Carbohydrate Drink and Postoperative Insulin Resistance

Insulin Resistance | Inflammatory Response | Length of Stay | Exaggerated Well-Being

Bosnia and Herzegovina
Nermina Rizvanović

Completed

Preoperative Administration of Oral Carbohydrate Drink, Neutrophil/Lymphocyte Ratio and Postoperative Complications

Postoperative Complications | Lymphocyte | Neutrophil

Bosnia and Herzegovina
Hermina Heart Center Kemayoran
Hermina Hospital Group

Completed

Intraarterial Nitroglycerin Versus Nicardipine and Radial Artery Occlusion (NONERAO)

Vasodilation | Radial Artery Injury at Wrist and Hand Level | Occlusion of Artery

Indonesia
Hermina Heart Center Kemayoran

Unknown

Nitroglycerin as Spasmolytic Regimen for RAS Prevention in Radial Center (NORAS)

Radial Artery Injury

Indonesia
Derming SRL

Completed

Efficacy of an Antiage Aesthetic Treatment for the Middle and Inferior Third of the Face

Face Skin Laxity

Italy
Derming SRL

Completed

Aesthetic Performance of an Injective Treatment for the Inner Thighs, Knees and Arms

Skin Flaccidity Inner Thighs Knees Arms

Italy
Derming SRL

Completed

Soothing and Barrier Restoration Activity of a Body Cream for Atopic Skin

Atopic Dermatitis

Italy
Derming SRL

Completed

Aesthetic Performance of an Intradermal Injection Treatment for Face Photoaging: Interstitial or Cushion Technique in Comparison to Bolus Technique at Five Points (Half - Face Method Within Subjects)

Face Photoaging

Italy
Derming SRL

Completed

Evaluation of the Filler Performance on the Nasolabial Folds of Aliaxin® EV With and Without Lidocaine 0.3%

Nasolabial Folds Correction

Italy
Derming SRL

Completed

Efficacy and Tolerance Evaluation of a Topical "Revitalizing" Face Day Cream

Healthy

Italy
Derming SRL

Completed

Clinical Trial on a Topical "Antiage" Face Gel (E2912)

Wrinkles

Italy
Derming SRL

Completed

Aesthetic Performance of "Profhilo®" Injective Intradermal Treatment for the Neck

Skin Manifestations

Italy
Derming SRL

Completed

Aesthetic Performance of an Injective Treatment for the Skin Roughness and Laxity of Inner Arm and Abdomen

Skin Flaccidity and Roughness of the Abdomen and Inner Arms

Italy
Derming SRL

Completed

Efficacy and Tolerance Evaluation of an Amino Acid Food Supplement

Skin Photoaging

Italy
Derming SRL

Completed

Soothing and Re-epithelizing Activity of New Cosmetic Formulations in Comparison to Placebo and Untreated Control Area

Sensitive Skin

Italy
Derming SRL

Completed

Efficacy Evaluation of the Activity of a Cosmetic Product (Topical Use) on Hair Regrowth vs Placebo

Hypertrichosis

Italy
Derming SRL

Completed

Face Photoaging: Efficacy and Tolerance Evaluation of an Intradermal Injective Treatment

Face Skin Photoaging
Derming SRL

Completed

Clinical Study for the Evaluation of P-3075 Cream on Acne Treatment (ANTI-ACNE)

Acne

Italy
Derming SRL

Completed

Humectant Activity of a New Formulation of Gynomunal® Vaginalgel (GYNOMUNAL®)

Menopause | Vaginal Dryness

Italy
Derming SRL

Completed

Efficacy and Tolerance Evaluation of an Injective Treatment for the Area Around the Eyes

Under-eyes Dark Circles

Italy
Derming SRL

Completed

Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)

Malar and Sub-malar Volume Deficiency

Italy
Derming SRL

Completed

Hydrating Efficacy and Tolerance Evaluation of a Face Cream

Dry and Damaged Skin

Italy
Derming SRL

Completed

Efficacy and Tolerance Evaluation of a "Revitalizing" Face Treatment

Face Aging/Photo Aging of Moderate Grade

Italy
Derming SRL

Completed

Evaluation of Tolerance and Trichological Efficacy of a Food Supplement

Telogen Effluvium
Derming SRL

Completed

Efficacy and Tolerance Evaluation of an Anti-age Food Supplement

Moderate-severe Skin Aging/Photoaging
Derming SRL

Completed

Efficacy and Tolerance Evaluation of a Bio-revitalizing Product Containing Hyaluronic Acid With High and Low Molecular Weight

Malar and Sub-malar Volume Deficiency

Italy
Derming SRL

Completed

Short Term Evaluation of the Soothing and Re-epithelizing Activity of Three Topical Products and Relative Combinations

Healthy

Italy
Derming SRL

Completed

Clinical Study for the Evaluation of the Depigmenting Activity of a Cosmetic Product on Spotted Hand Skin

Healthy

Italy
Derming SRL

Completed

Evaluation of the Activity of a Pharmacological "Anticellulitis" Product vs. a Reference Product on the Market

Healthy
Serina Therapeutics

Active, not recruiting

A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214

Parkinson's Disease

United States
Adele Sparavigna

Unknown

Tolerance and Efficacy Evaluation of 3 Face Creams (FILLER)

Skin Aging

Italy
Faculty of Medicine, Tarumanagara University
Hermina Podomoro Hospital

Completed

Diabetes in Pregnancy and Pregnancy Outcomes

Diabetes, Gestational | Diabetes Mellitus in Pregnancy
ENRICO VERRINA

Unknown

Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)

Secondary Hyperparathyroidism

Italy
Eli Lilly and Company
Dermira, Inc.

Completed

Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. (ADhere)

Atopic Dermatitis

United States, Canada, Germany, Poland
Dermira, Inc.

Completed

A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris

Acne Vulgaris

United States, Canada
Dermira, Inc.

Completed

A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis

Psoriasis

Canada
Dermira, Inc.

Completed

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States, Canada, Australia
Dermira, Inc.

Completed

A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel

Acne Vulgaris

Canada
Eli Lilly and Company
Dermira, Inc.

Completed

A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis

United States
Derming SRL
University of Bologna

Completed

High Total Antioxidant Capacity Products Added to Diet

Healthy

Italy
Faculty of Medicine, Tarumanagara University
Hermina Podomoro Hospital

Completed

Glycated Hemoglobin Targets and Glycemic Control in Indonesian Diabetic Patients

Diabetes Mellitus
Eli Lilly and Company
Dermira, Inc.

Recruiting

A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis (ADorable-1)

Eczema | Atopic Dermatitis

United States, Taiwan, Spain, Australia, Mexico, Canada, Germany, Japan, Brazil, Argentina, Poland, Czechia, France
Eli Lilly and Company
Dermira, Inc.

Completed

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate2)

Atopic Dermatitis

United States, Canada, Taiwan, Singapore, Germany, Bulgaria, Ukraine, Mexico
Eli Lilly and Company
Dermira, Inc.

Completed

Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis (ADore)

Atopic Dermatitis

United States, Canada, Australia, Poland
Eli Lilly and Company
Dermira, Inc.

Completed

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)

Atopic Dermatitis

United States, Spain, Korea, Republic of, Australia, France, Canada, Estonia, Latvia, Lithuania, Poland
Dermira, Inc.

Completed

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States, Canada, Australia
Dermira, Inc.

Completed

Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild Acne

Acne

Canada
Nereida Canosa Rodríguez

Recruiting

Study on Mental Health-related Stigma

Mental Health Disorder

Spain
IBSA Farmaceutici Italia Srl
Derming SRL

Completed

Evaluation of Efficacy and Safety of HCC_45 for the Correction of Acne Scars of the Face

Acne Scars - Mixed Atrophic and Hypertrophic | Ice Pick Scars | Rolling Scars | Boxcar Scars

Italy
Eli Lilly and Company
Dermira, Inc.

Active, not recruiting

Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) (ADjoin)

Atopic Dermatitis

United States, Spain, Canada, France, Korea, Republic of, Taiwan, Australia, Germany, Bulgaria, Estonia, Latvia, Lithuania, Mexico, Poland, Singapore, Ukraine

3

Subscribe